Read Time:5 Second
The first-quarter results come as Merck shows substantial progress in preparing for Keytruda’s patent expiration in 2028.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating